Skip to main content

Advertisement

SpringerLink
Log in

The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma

  • Original Article – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Basal cell carcinoma (BCC) is the most prevalent cancer worldwide. Different mechanisms are proposed to be involved in its pathogenesis such as oxidative stress. Oxidative stress, which is the consequence of the disruption of redox balance in favor of oxidants, is involved in the initiation or progression of many tumors. Thioredoxin reductase (TrxR) is a key enzyme of the thioredoxin (Trx) system, containing Trx and TrxR and NADPH, which is one of the main cellular oxidoreductases with an essential role in cellular health and survival through providing and maintaining redox balance. Therefore, we aimed to study and compare the activity and tissue distribution of TrxR in tumoral tissue and its healthy margin in patients with BCC.

Methods

After biopsy and taking samples from 18 patients, TrxR activity was measured using a commercial kit and its tissue distribution was assessed immunohistochemically.

Results

Both the activity and tissue distribution of TrxR in tumoral tissues were significantly higher compared to their healthy margins. Regarding the tissue distribution, this significant increase in TrxR in tumoral tissues was documented based on both staining intensity and abundance of positive cells in immunohistochemistry.

Conclusions

Based on these results, it is concluded that TrxR is involved in the pathogenesis of BCC; however, more investigations are required to clarify whether this increase is a consequence of BCC or it is an initiating mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Amirchaghmaghi M et al (2016) Evaluation of plasma isoprostane in patients with oral lichen planus. J Dent 17:21–25

    Google Scholar 

  • Arner ES, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420–426. doi:10.1016/j.semcancer.2006.10.009

    Article  CAS  PubMed  Google Scholar 

  • Cheraskin E (1996) Antioxidants in health and disease. J Am Optom Assoc 67:50–57

    CAS  PubMed  Google Scholar 

  • Cretnik M et al (2009) Involvement of p16 and PTCH in pathogenesis of melanoma and basal cell carcinoma. Int J Oncol 34:1045–1050

    CAS  PubMed  Google Scholar 

  • Deng M, Marsch AF, Petronic-Rosic V (2015) Basal cell carcinoma: part 1—basal cell carcinoma has come of age. Skinmed 13:206–213; quiz 214

  • Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655–673

    Article  CAS  PubMed  Google Scholar 

  • Didier C, Kerblat I, Drouet C, Favier A, Beani JC, Richard MJ (2001) Induction of thioredoxin by ultraviolet: a radiation prevents oxidative-mediated cell death in human skin fibroblasts. Free Radic Biol Med 31:585–598

    Article  CAS  PubMed  Google Scholar 

  • Flores LC et al (2012) Thioredoxin, oxidative stress, cancer and aging. Longev Healthspan 1:4. doi:10.1186/2046-2395-1-4

    Article  PubMed  PubMed Central  Google Scholar 

  • Fujii J, Kurahashi T, Konno T, Homma T, Iuchi Y (2015) Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus. World J Nephrol 4:213–222. doi:10.5527/wjn.v4.i2.213

    Article  PubMed  PubMed Central  Google Scholar 

  • Goppner D, Leverkus M (2011) Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease. J Skin Cancer 2011:650258. doi:10.1155/2011/650258

    PubMed  Google Scholar 

  • Gupta RK et al (2014) Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev: APJCP 15:4405–4409

    Article  PubMed  Google Scholar 

  • Halliwell B (1996) Antioxidants in human health and disease. Annu Rev Nutr 16:33–50. doi:10.1146/annurev.nu.16.070196.000341

    Article  CAS  PubMed  Google Scholar 

  • Hashemy SI (2011) The human thioredoxin system: modifications and clinical applications. Iran J Basic Med Sci 14:191–204

    CAS  Google Scholar 

  • Hashemy SI, Gharaei S, Vasigh S, Kargozar S, Alirezaei B, Keyhani FJ, Amirchaghmaghi M (2016) Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment. J Oral Pathol Med 45:35–40. doi:10.1111/jop.12326

    Article  CAS  PubMed  Google Scholar 

  • Iwasaki JK, Srivastava D, Moy RL, Lin HJ, Kouba DJ (2012) The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol 66:e167–e178. doi:10.1016/j.jaad.2010.06.054

    Article  CAS  PubMed  Google Scholar 

  • Kaffe ET, Rigopoulou EI, Koukoulis GK, Dalekos GN, Moulas AN (2015) Oxidative stress and antioxidant status in patients with autoimmune liver diseases Redox report: communications in free radical research 20:33–41. doi:10.1179/1351000214Y.0000000101

    CAS  PubMed  Google Scholar 

  • Kilic N, Yavuz Taslipinar M, Guney Y, Tekin E, Onuk E (2014) An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer. Ann Surg Oncol 21:4139–4143. doi:10.1245/s10434-014-3859-3

    Article  PubMed  Google Scholar 

  • Kim SJ et al (2005) High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res 11:8425–8430. doi:10.1158/1078-0432.CCR-05-0449

    Article  CAS  PubMed  Google Scholar 

  • Kumar S, Holmgren A (1999) Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis 20:1761–1767

    Article  CAS  PubMed  Google Scholar 

  • Li C, Athar M (2016) Ionizing radiation exposure and basal cell carcinoma pathogenesis. Radiat Res 185:217–228. doi:10.1667/RR4284.S1

    Article  CAS  PubMed  Google Scholar 

  • Lillig CH, Holmgren A (2007) Thioredoxin and related molecules: from biology to health and disease. Antioxid Redox Signal 9:25–47. doi:10.1089/ars.2007.9.25

    Article  CAS  PubMed  Google Scholar 

  • Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M (2013) The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal 19:1266–1303. doi:10.1089/ars.2012.4757

    Article  CAS  PubMed  Google Scholar 

  • Marzano C, Gandin V, Folda A, Scutari G, Bindoli A, Rigobello MP (2007) Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med 42:872–881. doi:10.1016/j.freeradbiomed.2006.12.021

    Article  CAS  PubMed  Google Scholar 

  • Mei Y, Thompson MD, Cohen RA, Tong X (2015) Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta 1852:243–251. doi:10.1016/j.bbadis.2014.05.005

    Article  CAS  PubMed  Google Scholar 

  • Milkovic L, Siems W, Siems R, Zarkovic N (2014) Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer. Curr Pharm Des 20:6529–6542

    Article  CAS  PubMed  Google Scholar 

  • Mustacich D et al (2004) Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse. Carcinogenesis 25:1983–1989. doi:10.1093/carcin/bgh195

    Article  CAS  PubMed  Google Scholar 

  • Nakamura H et al (2000) Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer. Cancer Detect Prev 24:53–60

    CAS  PubMed  Google Scholar 

  • Nazoury M, Hosseini-Zijoud SM, Soukhtanloo M, Mashkani B, Hashemy SI (2014) Determination of in vitro and in vivo protective effects of Ghrelin against oxidative stress: experimental study. J Appl Pharm Sci 4:008–013. doi:10.7324/JAPS.2014.41202

    Google Scholar 

  • Niu BZ, Chen G, Li LJ, Wu YD, Zhao YP (2005) [Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine] Zhongguo yi xue ke xue yuan xue bao. Acta Acad Med Sin 27:606–610

    CAS  Google Scholar 

  • Ono R, Masaki T, Dien S, Yu X, Fukunaga A, Yodoi J, Nishigori C (2012) Suppressive effect of recombinant human thioredoxin on ultraviolet light-induced inflammation and apoptosis in murine skin. J Dermatol 39:843–851. doi:10.1111/j.1346-8138.2012.01566.x

    Article  CAS  PubMed  Google Scholar 

  • Razi S, Enayatrad M, Mohammadian-Hafshejani A, Salehiniya H, Fathali-Loy-Dizaji M, Soltani S (2015) The Epidemiology of skin cancer and its trend in Iran. Int J Prev Med 6:64. doi:10.4103/2008-7802.161074

    PubMed  PubMed Central  Google Scholar 

  • Sander CS, Hamm F, Elsner P, Thiele JJ (2003) Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 148:913–922

    Article  CAS  PubMed  Google Scholar 

  • Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ (2004) Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 43:326–335. doi:10.1111/j.1365-4632.2004.02222.x

    Article  CAS  PubMed  Google Scholar 

  • Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC (2009) Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11:2985–3011. doi:10.1089/ARS.2009.2513

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shah AA, Sinha AA (2013) Oxidative stress and autoimmune skin disease. Eur J Dermatol: EJD 23:5–13. doi:10.1684/ejd.2012.1884

    CAS  PubMed  Google Scholar 

  • Shimizu M, Saitoh Y, Itoh H (1990) Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol 21:607–612

    Article  CAS  PubMed  Google Scholar 

  • Smith AD, Levander OA (2002) High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol 347:113–121

    Article  CAS  PubMed  Google Scholar 

  • Stroes ES, Rabelink TJ, Van Faassen EE (1998) Redox state and health: a persisting challenge. Eur J Clin Invest 28:884–885

    Article  CAS  PubMed  Google Scholar 

  • Szumiel I (2015) Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria. Int J Radiat Biol 91:1–12. doi:10.3109/09553002.2014.934929

    Article  CAS  PubMed  Google Scholar 

  • Taheri A, Tanipour MH, Khorasani ZK, Kiafar B, Layegh P, Hashemy SI (2016) Serum protein carbonyl and total antioxidant capacity levels in pemphigus vulgaris and bullous pemphigoid Iranian. J Dermatol 18:156–162

    Google Scholar 

  • Vural P, Canbaz M, Selcuki D (1999) Plasma antioxidant defense in actinic keratosis and basal cell carcinoma. J Eur Acad Dermatol Venereol: JEADV 13:96–101

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Yang H, Li W, Xu H, Yang X, Gan L (2015) Thioredoxin 1 upregulates FOXO1 transcriptional activity in drug resistance in ovarian cancer cells. Biochim Biophys Acta 1852:395–405. doi:10.1016/j.bbadis.2014.12.002

    Article  CAS  PubMed  Google Scholar 

  • Yan C, Siegel D, Newsome J, Chilloux A, Moody CJ, Ross D (2012) Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling. Mol Pharmacol 81:401–410. doi:10.1124/mol.111.076091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoshida T, Goto S, Kawakatsu M, Urata Y, Li TS (2012) Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation. Free Radic Res 46:147–153. doi:10.3109/10715762.2011.645207

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are very grateful to all patients who participated in this study. This work was based on the Research Project No. 901151, as the MD dissertation of Maryam Sobhani, financed by the Research Council of Mashhad University of Medical Sciences.

Funding

This study was funded by Mashhad University of Medical Sciences.

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Maryam Sobhani

  2. Department of Dermatology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Ahmad-Reza Taheri

  3. Department of Pathology, Qaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Amir-Hossein Jafarian

  4. Surgical Oncology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran

    Seyed Isaac Hashemy

Authors
  1. Maryam Sobhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad-Reza Taheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amir-Hossein Jafarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyed Isaac Hashemy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seyed Isaac Hashemy.

Ethics declarations

Conflict of interest

All authors declare that there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards (Ethical code from Mashhad University of Medical Sciences: 901151).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sobhani, M., Taheri, AR., Jafarian, AH. et al. The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma. J Cancer Res Clin Oncol 142, 2303–2307 (2016). https://doi.org/10.1007/s00432-016-2242-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-016-2242-0

Keywords

Search

Navigation